Skip to main content

Security report for boehringer-ingelheim.com

Boehringer Ingelheim · Healthcare · Germany

Medium risk. 5 critical or high findings in Security headers, GDPR outside view and 1 other check.

Security score

72/100

Risk levelMedium

0–100, higher is better. How it is calculated

Boehringer Ingelheim is a large global pharmaceutical company focused on improving life for people and animals through innovative healthcare products and research. The website reflects a mature digital presence with multilingual support and professional branding. Technically, the site uses Drupal CMS with modern web technologies and good performance optimizations. Security posture is strong with HTTPS, security headers, and secure forms, though explicit security policies and incident response details are not publicly disclosed. Privacy compliance is well addressed with clear privacy and cookie policies and consent mechanisms. The missing WHOIS data is a notable anomaly but does not detract significantly from the overall legitimacy given the website's quality and trust signals. Overall, the site is professional, secure, and compliant with minor areas for improvement in transparency and WHOIS data availability.

Scanned

NIS2 and GDPR posture

GDPR outside view
73/ 100 · Medium
Checks completed
7of 7

NIS2 Art. 21(2)

  1. (a) Risk analysis and security policies: Not visible from outside
  2. (b) Incident handling: One indicator
  3. (c) Business continuity, backups and crisis management: Not visible from outside
  4. (d) Supply chain security: Not visible from outside
  5. (e) Secure acquisition, development and maintenance, including vulnerability handling: Partly checked
  6. (f) Assessing the effectiveness of security measures: Not visible from outside
  7. (g) Cyber hygiene and security training: Not visible from outside
  8. (h) Cryptography and encryption: Partly checked
  9. (i) HR security, access control and asset management: One indicator
  10. (j) Multi-factor authentication and secured communications: Not visible from outside

This scan rated NIS2 with an earlier keyword method that is no longer shown; rescan for the per-article view. Risk management, continuity, supply chain, training, MFA, management oversight (Art. 20) and incident reporting (Art. 23) need internal evidence, and Guard cannot tell whether NIS2 applies to this organisation.

GDPR is indicative only, based on publicly visible signals: Articles 7, 12, 13 and 32 of Regulation (EU) 2016/679 and Article 5(3) of the ePrivacy Directive. Not a certification or legal assessment.

Priority findings

5 findings rated critical or high. Fix these first.

  1. Security headers

    Security headers are instructions your web server sends to every visitor’s browser. Missing ones leave visitors more exposed to attacks such as clickjacking and injected scripts.

    • High

      Missing Strict-Transport-Security header

      Forces HTTPS connections

      What to do: Add "Strict-Transport-Security: max-age=31536000; includeSubDomains; preload"

      • CWE-319
      • OWASP A04:2025
      • ASVS V3.4.1
    • High

      Missing X-Frame-Options header

      Prevents clickjacking attacks

      What to do: Add "X-Frame-Options: DENY" or "X-Frame-Options: SAMEORIGIN"

    • High

      Missing Content-Security-Policy header

      Controls resources the browser is allowed to load

      What to do: Implement a Content-Security-Policy appropriate for your application

      • ASVS V3.4.3
      • OWASP Secure Headers: OWASP Secure Headers Project recommends Content-Security-Policy: default-src 'self'; form-action 'self'; base-uri 'self'; object-src 'none';…
  2. GDPR outside view

    These are the privacy signals visitors and data protection authorities look for under GDPR.

    • High

      No Cookie Policy found

      GDPR requires clear information about cookie usage

      What to do: Add a dedicated cookie policy explaining cookie usage and purposes

  3. SSL/TLS

    TLS encrypts the connection and proves the site is really yours. Weak or expiring certificates trigger browser warnings and put traffic at risk.

    • High

      Weak Protocols Supported

      Server supports weak protocols: TLSv1.1

      What to do: Disable TLS 1.0, TLS 1.1, and all SSL versions

      • CWE-327
      • OWASP A04:2025
      • ASVS V12.1.1

Need hands-on remediation? Email guard@offseq.com

Keep watching boehringer-ingelheim.com

This scan found 18 issues across 6 checks. Monitoring re-runs those checks daily, emails you when something material changes and records each fix, so you can show progress.

Daily monitoring

Recommended

€25per month

  • TLS certificates and expiry
  • DNS records
  • SPF, DKIM and DMARC
  • Security headers
  • GDPR and NIS2 posture
  • Exposed services
  • Third-party trackers
  • Security score drift

Email alerts on material changes and an exportable JSON history of every change.

Billed monthly to your card. Cancel anytime. See sample alerts.

Full report

€39.90one-time

  • The complete analysis as a PDF you can cite
  • Email delivery with an unlock code
  • Lifetime access to this report

Prices incl. 21% VAT. Secure checkout by Mollie; sold by SEQ SIA, Latvia.

Results by check

Each check with its score, findings and the evidence it collected.

How this score is calculated

The security score runs 0–100, higher is better. It is the plain average of the security checks that completed in this scan, each counted equally. A check that could not run is left out: it counts neither as a pass nor as a fail.

Counted in this score

SSL/TLS
67
Security headers
20
Email security
85
DNS health
85
Network security
100
GDPR outside view
73
Average
72

Not counted

  • NIS2 outside view: Re-weights evidence from the TLS, email, DNS, network and hygiene checks, so counting it would count that evidence twice. Shown on its own.
  • OffSeq Observations: An AI reading of the site, useful context but not reproducible evidence. Shown on its own.

Findings that cap the score at 49

Each of these is serious on its own, so while any is present the site cannot rate better than high risk, however good the other checks are.

  • The certificate is not trusted by browsers
  • The website is not served over HTTPS
  • A database, remote desktop, file-sharing or Telnet service is reachable from the internet
  • The page loads a script from a compromised source
  • The domain registration has expired
  • SPF authorises every server to send mail as the domain

Partial scans

When the site blocks Guard or most checks cannot run, the score covers only the checks that ran (usually DNS and email), is capped at 75 and is shown as partial, without a risk level.

Risk levels

  • Critical0–25
  • High26–49
  • Medium50–75
  • Low76–100

Breach exposure

Leaked credentials and lookalike domains from OffSeq Breach. The counts are free; the detailed lists are paid add-ons.

Dark web exposure

Add-on

Leaked records that mention boehringer-ingelheim.com, from OffSeq Breach.

Total records
1,968
Employees
20
Customers
836
Third parties
1,112
Weak passwords
21%

Latest record dated 2026-06-08 · 62 subdomains affected

See the 10 newest leaked credentials

A one-off add-on to this report that lists the most recent identifier and password pairs OffSeq Breach holds for boehringer-ingelheim.com.

Select it in the checkout above.

Masked preview

  • –guestportal2.boehringer-ingelheim.com2026-06-08
  • –myworkspace-eu.boehringer-ingelheim.com2026-05-21
  • –myworkspace.boehringer-ingelheim.com2026-05-13
  • –myworkspace-eu.boehringer-ingelheim.com2025-11-12
  • –myworkspace-eu.boehringer-ingelheim.com2025-10-31

Breach keeps ingesting new leaks, so these numbers can grow between scans.

Technical appendix

Business context, site observations and technical notes gathered during the scan, and the standards behind each reference.

Business context

Business profile

The company operates in the healthcare sector with a focus on pharmaceuticals for humans and animals. It targets healthcare professionals, patients, and the general public globally. The business model centers on research, development, and distribution of healthcare products. The website supports multiple regions and languages, indicating a broad international market presence. The company maintains a strong brand identity and trust through comprehensive content, privacy compliance, and social media engagement. No direct revenue streams or e-commerce functions are evident on the site, consistent with a B2B and informational corporate model. The absence of WHOIS data is unusual but may be due to privacy protection or registry issues. The company appears to have a robust partnership and tracking ecosystem with custom analytics.

Security posture

The website demonstrates a high security maturity level with enforced HTTPS, multiple security headers, and secure form handling including anti-bot measures. No vulnerabilities or exposed sensitive data were detected in the analysis. However, the lack of a publicly available security policy, incident response plan, or vulnerability disclosure program limits transparency and could be improved. GDPR compliance is evident through privacy and cookie policies with consent mechanisms. The site uses custom tracking scripts but no major third-party ad networks, reducing exposure to third-party risks. Overall, the security posture is strong but could benefit from enhanced transparency and formal security disclosures.

Recommendations

  1. Publish a dedicated security policy and incident response information page to improve transparency.
  2. Implement and publicize a vulnerability disclosure program or security.txt file to encourage responsible reporting.
  3. Provide contact details for a Data Protection Officer or security contact to enhance trust and compliance.
  4. Monitor and resolve the missing WHOIS registration data to improve domain trustworthiness.
  5. Continue to maintain and update privacy and cookie compliance mechanisms in line with evolving regulations.
Site observations

Automated reading of the public site. Ratings are indicative.

Business

Company
Boehringer Ingelheim
Description
Learn how we change life for the better for people and animals.
Key services
Pharmaceutical products for human and animal health, Research and development, Healthcare information and resources
Content quality
excellent
Branding
consistent

Technology

Stack
Drupal CMS, LazySizes (lazy loading images), Google Fonts, JSON-LD structured data, Custom JavaScript libraries
Frameworks
GDS (Government Digital Service) style components
Performance
moderate
Mobile
good
Accessibility
good
SEO
good

Security

Observed score
85/100
Good practices seen
  • HTTPS enforced
  • Security headers present
  • No exposed sensitive data detected
  • Secure forms with anti-bot measures

Analytics and tracking

Tracking level
moderate
Privacy practices
good

Advertising

Tracking pixels
bi-instatag.com
Marketing tools
bi-instatag.com tracking
Transparency
basic

Site quality

Design
excellent
User experience
excellent
Content relevance
excellent
Navigation
excellent
Professionalism
excellent
Trustworthiness
high

Key observations

  1. Website is fully accessible with rich content and multiple language/region options.
  2. Strong corporate branding and professional design.
  3. No signs of phishing, malware, or suspicious content.
  4. WHOIS data missing, which is uncommon and should be monitored.
  5. Good privacy and cookie compliance with consent mechanisms.
  6. No explicit security policy or incident response info publicly available.
  7. Use of custom tracking scripts but no major third-party ad networks detected.
Technical notes

Notes

The website is built on Drupal CMS with a modern tech stack including lazy loading for images and JSON-LD structured data for SEO. It uses custom JavaScript libraries and GDS style components for UI consistency. Performance is moderate with good mobile optimization and accessibility features. SEO is well implemented with comprehensive meta tags and Open Graph data. Hosting provider details are not explicitly identified. The site is well maintained technically with no broken elements or errors detected. Opportunities exist to enhance technical transparency around hosting and security infrastructure.
Standards and sources

Reference chips under each finding point to the standard, regulation or specification the finding relates to. They are taken from the official datasets below and mapped conservatively: a finding with no defensible link shows none. NIS2 and GDPR references mark where a finding is relevant evidence, not a compliance verdict. Implementing Regulation (EU) 2024/2690 binds digital infrastructure and digital service providers; for other entities it is the most detailed public reading of the Article 21 measures. WCAG, EN 301 549, European Accessibility Act and Web Accessibility Directive references name the requirement an automated accessibility rule relates to; they are not a conformance verdict.

Retrieved 2026-10-25

Earlier scans of this domain

  1. 45/100High25 findingsView report
  2. 45/100High25 findingsView report
Reviews of this site

Share your experience with boehringer-ingelheim.com. Every review is verified by email and published after moderation.

Overall rating
Select a rating
4000 characters remaining

We’ll email you to confirm your review and keep your details private.

Community rating

No published reviews yet. Be the first to review boehringer-ingelheim.com.

Feedback on this report

Rate this report, add an optional comment, and tell us if you want a security specialist to follow up.

Overall report quality
Select a rating
2000 characters remaining

We only use your feedback to improve Guard reports. Contact details are never shared.